Menu Close

== CD-ELISA performed with DONPEP-AP fusion protein

== CD-ELISA performed with DONPEP-AP fusion protein. with each other for mAb 6F5 binding. When translationally fused with bacterial alkaline phosphatase, DONPEP.2 bound specifically to mAb 6F5, while the fusion protein retained alkaline phosphatase activity. The potential of using DONPEP.2 while an immunochemical reagent inside a DON immunoassay was evaluated having a DON-spiked wheat draw out. When peptide C430 was conjugated to bovine serum albumin, it elicited antibody specific to peptide C430 but not to DON in both mice and rabbits. In an in Pyrimethamine vitro translation system comprising rabbit reticulocyte lysate, synthetic peptide C430 did not inhibit protein synthesis but did display antagonism toward DON-induced protein synthesis inhibition. These data suggest that the peptides selected in this study bind to mAb 6F5 and that peptide C430 binds to ribosomes at the same sites as DON. Deoxynivalenol (DON) (vomitoxin) (Fig.1A) is one of the sesquiterpene mycotoxins classified while 12,13-epoxy-trichothecenes (28). This compound occurs naturally in infected corn (19,29), small grains (18,31), and combined feeds (29). DON is mainly produced by the fungusGibberella zeae(Schwein.) Petch (anamorph,Fusarium graminearumSchwabe). In the cellular level, the main toxic effect of DON is definitely inhibition of protein synthesis via binding to ribosomes and interfering with peptidyltransferase (4,42). In animals, DON can cause anorexia and emesis (vomiting) (37). Additional toxic effects of DON include pores and skin irritation, hemorrhaging, hematological changes, human being lymphocyte blastogenesis impairment, radiomimetic effects, apoptosis (cytotoxicity), and immunotoxicity (37). == FIG. 1. == Structural assessment of DON and nivalenol with DON mimotope peptide SWGPFPF (DONPEP.2). (A) Two-dimensional representation of DON. The asterisk shows the site of conjugation of the carrier protein (e.g., BSA) to DON. (B) Two-dimensional structure of nivalenol, an analog of DON whose structure is known. (C) Three-dimensional structural model of the DON mimotope peptide. The white spheres represent oxygen atoms, the white cylinders represent nitrogen atoms, and the gray cylinders represent carbon atoms in panels C through E. (D) Three-dimensional stereo view of the crystallographic structure of nivalenol (CSD access DUTJOR10 [4a]). (E) Stereo view of the optimal PowerFit superposition of the known nivalenol structure and the DON mimotope peptide structure. Nivalenol aligns with the peptide model main-chain atoms between residues 2 and 5 (TrpGlyProPhe) and partially overlaps the side chains or Trp-2 and Pro-4. A major way to remove DON from human being and animal food is definitely to detect contaminated raw materials and divert them from feed and finished food. Compared with additional analytic methods, immunoassays have several advantages for quick field screening, including high specificity, level of sensitivity, facile sample preparation, and ease of use (33). Following a development of the 1st monoclonal antibody (mAb) to DON (6), immunological methods, primarily Pyrimethamine an enzyme-linked immunosorbent assay (ELISA), have been used widely for detection of DON (33). Regrettably, the effectiveness of chemical conjugation of DON to a carrier protein or an enzyme is definitely low because such conjugation entails extensive changes and blocking phases and causes considerable bridge group interference and undesirable cross-reactions (6,33,45). Also, when DON is definitely conjugated to a carrier protein, it is weakly immunogenic. Finally, since DON is definitely harmful and is included as a standard and conjugate in immunoassay mixtures, it may present a toxicity risk to kit Pyrimethamine users. One possible alternative to using mycotoxins as immunochemical reagents is definitely to develop protein or peptide mimics that serve the same function. One approach for doing this is via generation of anti-idiotype antibodies (7,9,23), whose constructions mimic the surface constructions of low-molecular-weight biological toxins. Sometimes the level of sensitivity of the original antibody can be improved by generating anti-anti-idiotype antibodies (8). However, these techniques are time-consuming and expensive. A new technique, phage display, allows foreign peptides and proteins to be genetically fused to the N terminus of small coat protein g3p of the filamentous phage fd, which results in display of the peptides and proteins on the surface of the virion (40). Since random oligonucleotide sequences are put into the g3 gene of filamentous phage fd, phage display provides a way to construct considerable peptide libraries that may be screened in order to select peptides with specific affinities or activities (14,15,39). Phage-displayed short peptide libraries have been widely used in a number of applications (12,24), including epitope mapping (14,39), mapping of LRP12 antibody protein-protein contacts (22), recognition of protease substrates (41), and recognition of integrin (32) and additional receptors (16), antagonists (35), and ligands (24). Only a few workers have used this technology to select peptide mimics of nonproteinaceous chemicals other than biotin (43) and carbohydrates (21). Given the feasibility of selecting peptides that mimic nonproteinaceous chemicals, we were interested in determining whether peptide mimics of low-molecular-weight mycotoxins could possibly be identified. Once chosen,.